1[1]Beasley C M Jr,Tollefson G D,Tran P V.Efficacy of olanzapine:an overview of pivotal trials.J Clin Psychiatry,1997,58 (Suppl 10):7～12
2[2]Beasley C M Jr,Hamilton S H,Crawford A M,et al.Olanzapine versus haloperidol:acute phase results of the international doubleblind olanzapine trial.Eur Neuropsychopharmacology,1997,7:125～137
3[3]Tollefson G D,Beasley C M Jr,Tran P V,et al.Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaaffective and schizophreniform disorder:results of an international collaborative trial.Am J Psychiatry,1997,154:457～465
4[4]Beasley C M Jr,Tollefson G D,Tran P V.Safety of olanzapine.J Clin Psychiatry,1997,58(Suppl 10):13～17
5Jeste DV, Eastham LH, Lacro JP, et al. Management of late-life psychosis. J Clin Psychiatry,1996,57(suppl 3): 39
6Reynolds GP. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia. Acta Psychiatr Scand,1994,89:36
7Zarate CA, Baldessarini RJ, Siegel AJ. Risperidone in the elderly: a pharmacoepidemiologic study. J Clin Psychiatry,1997,7:311
8C. M. Beasley,T. Sanger,W. Satterlee,G. Tollefson,P. Tran,S. Hamilton. Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial[J] 1996,Psychopharmacology(1-2):159～167
3Jablensky A.Prevalence and incidence of schizophrenia spectrum Disorders:implications for prevention[J].Aust N Z J Psychiatry,2000,34 (Suppl.):S26-S34.
4FM LM,Ji LP,Shen YC.Epidemiological survey on mental disability And intellectual 7 areas of China[J].Zhonghua Jingshenke Zazhi,1999,31(2):81-83.
5Guo SQ,Lv LX,Li Q,et al.Comparison of social disability and Social support in first episode schizophrenia patient[J].Zhongguo Linchuang Kangfu,2003,7(15):2 198-2 199.
6Lambert E,Naber D.Current issues in schizophrenia:overview Of patient acceptability,functioning capacity and quality of life[J].CNS Drugs,2004,18:1-13.
7Georg Juckel,Daniela Schaub,Nina Fuchs,et al.Validation of the Personal Performance(PSP)Scale in a German sample of acutely ill patients with Schizophrenia[J].Schizophrenia Research,2008,(104):287-293.
8Gureje O,Miles W,Keks N,et al.Olanzapine vs risperidone in the Management of schizophrenia a randomized clonble-blind trial In Australia and New Zealand[J].Schizophr Res,2003,61(2/3):303-314.
9Medalia A,Lim R.Treatment of cognitive dysfunction in Psychiatric disorders[J].J Psychiatric Practice,2004,10(1):17-25.
